CRP and type 1 diabetes mellitus: On the detrimental side, IL-6 is a key upstream driver of hepatic CRP synthesis and has been linked to endothelial dysfunction, insulin resistance, and systemic inflammatory activation, all of which may accelerate vascular complications in T1D [19].